Additionally, interleukin-6 is known to induce resistance of myeloma cells to chemo- and radiotherapy by NF-κB-dependent increase of manganese superoxide dismutase expression (MnSOD) [144]. The gene discussed is SOD2; the disease is plasma cell myeloma.